AI assistant
Sending…
Merck & Co., Inc. — Director's Dealing 2010
Feb 22, 2010
284_dirs_2010-02-22_2d0c8703-4297-4278-bb03-5875fcbc3dcc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Merck & Co. Inc. (MRK)
CIK: 0000310158
Period of Report: 2010-02-19
Reporting Person: KOHAN RAUL E (Exe V-P & Pres, Animal Health)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-02-19 | Restricted Stock Unit | $0 | A | 21339 | Acquired | 2013-02-19 | Common Stock (21339) | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
More from Merck & Co., Inc.
Regulatory Filings
2026
May 29
Declaration of Voting Results & Voting Rights Announcements
2026
May 28
Capital/Financing Update
2026
May 22
Capital/Financing Update
2026
May 20
Capital/Financing Update
2026
May 18
Capital/Financing Update
2026
May 18
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 4
Major Shareholding Notification
2026
Apr 30
Earnings Release
2026
Apr 30